Senior Director, Patient-Centred Outcomes Strategy & HTA Biometry
Added 22 Sept · still live
Likely
Sponsorship likelihood
This employer has issued visas recently
Not disclosed
Salary
Not disclosed by employer
£54,400
Going rate
Skilled Worker going rate
This role likely qualifies for a Skilled Worker visa
SOC 2161 (62% match) is an eligible occupation, with a going rate of £54,400, and Ipsen is a licensed sponsor. That is our reading of the rules. Whether they issue a Certificate of Sponsorship is still their call.
We pick the code from the advert's text, so it is our best guess, not the employer's. Each code it could be has its own likelihood:
- Likely 2161 (Research and development (R&D) managers) · 62% match
- Likely 2113 (Biochemists and biomedical scientists) · 20% match
- Likely 1139 (Functional managers and directors not elsewhere classified) · 7% match
Your salary route
New graduate or PhD holder? Pick one of the lower rates.
What each route needs for this job
| Occupation code | New entrant 70% of going rate | STEM PhD 80% of going rate | Relevant PhD 90% of going rate | Standard rate 100% of going rate |
|---|---|---|---|---|
2161 Research and development (R&D) managers Most likely code | £38,100 | £43,500 | £48,900 | £54,400 |
1139 Functional managers and directors not elsewhere classified Also possible | £52,300 | £59,700 | £67,200 | £74,700 |
We use the lowest threshold across the plausible codes. Likelihood is Possible at most when the pay clears only a lower rate, or only under a less likely code. How the Home Office picks the code
About the role
WHAT - Summary & Purpose Of The Position
The Senior Director, Patient-Centred Outcomes Strategy & Heath Technology Assessment (HTA) Biometry provides enterprise leadership for COA (Clinical Outcome Assessment) strategy across Ipsen’s R&D portfolio, with specific accountability for Patient Reported Outcomes (PRO) strategy, questionnaire development, measurement strategy, validation, implementation, and interpretation.
The role ensures patient experience, symptoms, functioning, quality of life, treatment burden, and treatment benefit are captured robustly and integrated into development strategy, study documents, regulatory interactions, publications, and value evidence materials.
In parallel, the role leads HTA Biometry, including statistics and programming supporting HTA, reimbursement, payer evidence, comparative effectiveness, evidence synthesis, and value demonstration, with accountability for quality, timelines, prioritization, execution, and internal or outsourced delivery.
Working in a global matrix, the role partners with Clinical Development, Global Value and Access including HEOR, Regulatory Affairs, Medical Writing, Clinical Operations, Data Management, vendors, and external experts to build capability, develop talent, drive excellence, promote innovation, and position Biometry as a strategic partner in patient-centered evidence and HTA decision support.
WHAT - Main Responsibilities & Technical Competencies
PRO / COA remit
The Senior Director, Patient-Centred Outcomes Strategy & Heath Technology Assessment (HTA) Biometry provides enterprise leadership for COA (Clinical Outcome Assessment) strategy across Ipsen’s R&D portfolio, with specific accountability for Patient Reported Outcomes (PRO) strategy, questionnaire development, measurement strategy, validation, implementation, and interpretation.
The role ensures patient experience, symptoms, functioning, quality of life, treatment burden, and treatment benefit are captured robustly and integrated into development strategy, study documents, regulatory interactions, publications, and value evidence materials.
In parallel, the role leads HTA Biometry, including statistics and programming supporting HTA, reimbursement, payer evidence, comparative effectiveness, evidence synthesis, and value demonstration, with accountability for quality, timelines, prioritization, execution, and internal or outsourced delivery.
Working in a global matrix, the role partners with Clinical Development, Global Value and Access including HEOR, Regulatory Affairs, Medical Writing, Clinical Operations, Data Management, vendors, and external experts to build capability, develop talent, drive excellence, promote innovation, and position Biometry as a strategic partner in patient-centered evidence and HTA decision support.
WHAT - Main Responsibilities & Technical Competencies
PRO / COA remit
- Lead R&D COA measurement strategy across Ipsen programs, with deep expertise in PRO strategy and questionnaire development.
- Advise on disease models, concepts of interest, endpoint selection, questionnaire development, validation, treatment-benefit interpretation, and patient-focused evidence plans.
- Embed COA strategies into development plans, protocols, SAPs, regulatory documents, reports, publications, HTA materials, and value evidence outputs.
Advertisement
- Lead, coach, and develop the HTA Statistics and Programming team supporting Global Evidence & Outcomes with HEOR, including workforce planning, prioritization, capability development, performance support, succession planning, and operating model.
- Set priorities, standards, quality expectations, documentation requirements, resourcing plans, and capability roadmaps for HTA statistical analysis and programming.
- Oversee analyses supporting HTA submissions, reimbursement, comparative effectiveness, evidence synthesis, RWE, external controls, and value demonstration.
- Ensure internal and outsourced outputs are high quality, compliant, reproducible, and delivered to agreed timelines and budget using standard processes, templates, SOPs, and tools.
- Advance tools, automation, AI-enabled approaches, and innovative methods to improve efficiency, quality, and scalability across PRO/COA and HTA Biometry deliverables.
- Partner with Clinical Development, Global Value and Access including HEOR, Regulatory Affairs, Medical Writing, Clinical Operations, Data Management, and external experts on integrated patient-centered and HTA evidence strategies.
- Represent Biometry in governance, asset teams, portfolio discussions, external scientific interactions, and due diligence requiring COA, PRO, or HTA Biometry input.
Competency Behavioural Markers Rationale
Ensures Accountability
- Assigns clear ownership for tasks/projects
- Clarifies accountabilities and coaches others to do the same
- Seeks stakeholder input and drives consent-based decisions
- Owns decisions, outcomes, and follow-through Requires clear ownership of COA/PRO strategy and HTA analysis/programming quality, compliance, timelines, and delivery.
Advertisement
Develops/Coaches Talent
Drive Vision and Strategy
Manage Complexity
Communicates Effectively
HOW - Knowledge & Experience
Knowledge & Experience (essential):
- Aligns development goals with business needs
- Provides regular, actionable coaching and feedback
- Supports succession planning and team effectiveness
- Builds a human-centred, growth-focused culture
Drive Vision and Strategy
- Creates a compelling vision and strategy that motivates action
Manage Complexity
- Resolves conflicting inputs and demands
- Evaluates options and scenarios
- Prioritises what matters and makes impact-driven decisions
Communicates Effectively
- Listens actively and respects different perspectives
- Communicates transparently and respectfully
- Creates clear, structured, outcome-focused messages
- Demonstrates gravitas
HOW - Knowledge & Experience
Knowledge & Experience (essential):
- 10+ years’ relevant pharma, biotech, CRO, academic, or outcomes research experience with PhD, or equivalent MS/MSc experience, including significant leadership experience.
- Expertise in COA, especially PROs, including strategy, questionnaire development, selection, validation, implementation, and interpretation.
- Strong understanding of clinical development, regulatory expectations, and patient-centred evidence for treatment benefit.
- Statistical and programming knowledge for HTA evidence, reimbursement, comparative effectiveness, and value demonstration.
- Experience with ePRO, digital COA/endpoints, psychometrics, or modern questionnaire development and implementation.
- Experience with SAS and/or R programming concepts.
- Experience in oncology, rare disease or neuroscience drug development.
- Scientific publication record or external presence in HTA or outcomes research.
- MS/MSc or PhD in a relevant quantitative, clinical outcomes, psychometric, or health outcomes discipline.
- Fluent English, with excellent written and verbal communication.
This description is the source posting as it read when we added it. We are not affiliated with Ipsen, so check their own site for the current details.
Where this offer sits in the market
Research and development (R&D) managers (SOC 2161) · UK · ONS ASHE 2025 · basic pay · ~83k in sampleSOC 2161
- Middle half £45,448–73,580
- Median £56,992
- Going rate £54,400
- Threshold £41,700
- New entrant £38,100–48,900
Similar sponsored roles
See all UK visa jobsNo close matches live right now.
Browse more sponsored jobs at IpsenAbout sponsorship for this role
Does this job guarantee visa sponsorship?
Not necessarily. Ipsen holds a sponsor licence, but sponsorship for a specific hire is always the employer's decision. Be upfront in your application that you'll require it.
What salary is needed for this role to be eligible?
The offer must clear both the general threshold and the SOC 2161 going rate of £54,400. New-entrant and shortage discounts can lower it.